| |
 |
|
Class Information
Number: 530/387.1
Name: Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof > Proteins, i.e., more than 100 amino acid residues > Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc. > Globulins > Immunoglobulin, antibody, or fragment thereof, other than immunoglobulin antibody, or fragment thereof that is conjugated or absorbed
Description: Subject matter in which the protein has the structure of an immunoglobulin, antibody, or fragment thereof that is not conjugated or adsorbed to another substance.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 530/387.2 |
Anti-idiotypic |
203 |
| 530/387.7 |
Binds expression product of cancer-related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
564 |
| 530/387.5 |
Binds oligosaccharide structure |
188 |
| 530/387.9 |
Binds specifically-identified amino acid sequence |
1,425 |
| 530/387.3 |
Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rfv, immunoglobulin fusion protein, etc.) |
2,015 |
| 530/388.1 |
Monoclonal |
2,182 |
| 530/389.1 |
Polyclonal antibody or immunogloblin of identified binding specificity |
967 |
| 530/390.1 |
Removing or inactivating virus or bacterium or component or product thereof (e.g., endotoxin, etc.) |
107 |
| 530/390.5 |
Removing, dissociating, or preventing the formation of aggregated, denatured, fragmented, or polymerized immunoglobulin or antibody; or preventing or reducing complement fixation or binding; or reducing antigenicity; or removing, inactivating, or inhibiting contaminating plasma proteins (e.g., proteolytic enzymes, etc.) |
126 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7619069 |
Antibodies to TGF-beta 1 |
Nov. 17, 2009 |
| 7619068 |
Ovr110 antibody compositions and methods of use |
Nov. 17, 2009 |
| 7618783 |
Anthrax specific antibodies |
Nov. 17, 2009 |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7618629 |
Manipulation of cytokine levels using CD83 gene products |
Nov. 17, 2009 |
| 7618628 |
CD16A binding proteins and use for the treatment of immune disorders |
Nov. 17, 2009 |
| 7618627 |
Method of increasing radiation sensitivity by inhibition of beta one integrin |
Nov. 17, 2009 |
| 7615616 |
Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
Nov. 10, 2009 |
| 7615372 |
Antibodies with immune effector activity and that internalize in endosialin-positive cells |
Nov. 10, 2009 |
| 7615212 |
Compositions and methods for the systemic treatment of arthritis |
Nov. 10, 2009 |
| 7612178 |
Anti-IGF-1R antibodies and uses thereof |
Nov. 3, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7611706 |
RG1 antibodies and uses thereof |
Nov. 3, 2009 |
| 7611703 |
Kidney disease targets and uses thereof |
Nov. 3, 2009 |
| 7611702 |
TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
Nov. 3, 2009 |
| RE40948 |
APC antibodies |
Oct. 27, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7608695 |
Substance with antithrombotic activity and method for detecting glycokallidin |
Oct. 27, 2009 |
| 7608693 |
High affinity human antibodies to human IL-4 receptor |
Oct. 27, 2009 |
| 7608691 |
Antibodies against IL-16 antagonist peptides |
Oct. 27, 2009 |
| 7608690 |
IL-B30 antibodies |
Oct. 27, 2009 |
| 7608263 |
RG1 antibodies and uses thereof |
Oct. 27, 2009 |
| 7608240 |
Nanotubes for cancer therapy and diagnostics |
Oct. 27, 2009 |
| 7605237 |
High affinity human antibodies to human IL-4 receptor |
Oct. 20, 2009 |
| 7605233 |
Tumour necrosis factor binding ligands |
Oct. 20, 2009 |
| 7604947 |
Detection and modulation of cancer stem cells |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7604799 |
EphA4 Antibodies |
Oct. 20, 2009 |
| 7601825 |
Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer |
Oct. 13, 2009 |
| 7601816 |
Antibodies to cyclooxygenase variants |
Oct. 13, 2009 |
| 7601813 |
Anti-GL50 antibodies |
Oct. 13, 2009 |
| 7601508 |
Whitefly ecdysone receptor polypeptide and methods |
Oct. 13, 2009 |
| 7601351 |
Antibodies against protective antigen |
Oct. 13, 2009 |
| 7598352 |
Method of identifying polypeptide monobodies which bind to target proteins and use thereof |
Oct. 6, 2009 |
| 7598349 |
Antibodies to peptide fragments having cell death-inhibitory activity |
Oct. 6, 2009 |
| 7598051 |
Compositions and methods for the therapy and diagnosis of ovarian cancer |
Oct. 6, 2009 |
| 7597890 |
Methods and compositions for diagnosing lung cancer |
Oct. 6, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7597886 |
Tumor necrosis factor-gamma |
Oct. 6, 2009 |
| 7595292 |
Conjugated biological molecules and their preparation |
Sep. 29, 2009 |
| 7595051 |
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
Sep. 29, 2009 |
| 7595047 |
Compositions and methods for promoting or inhibiting angiogenesis |
Sep. 29, 2009 |
| 7592429 |
Sclerostin-binding antibody |
Sep. 22, 2009 |
| 7592145 |
Pin 1 as a marker for prostate cancer |
Sep. 22, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7592003 |
Regulation of toll-like receptors on stem cells |
Sep. 22, 2009 |
| 7589182 |
Anti-sulfotyrosine antibodies |
Sep. 15, 2009 |
| 7589180 |
Specific binding proteins and uses thereof |
Sep. 15, 2009 |
| 7589179 |
IL-7 variants with reduced immunogenicity |
Sep. 15, 2009 |
|
|
|
